Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Cambrex Corp.

TRADE

NYSE: CBMHealthcare / Biotechnology / USA
61.00+0.30+0.49%Vol 90 8831Y Perf 14.58%
Aug 15th, 2018 12:02
BID60.90 ASK61.00
Open60.70 Previous Close60.70
Pre-Market- After-Trading60.70
 - -%  - -%
Target Price
60.50 
Analyst Rating
Strong Buy 1.40
Potencial %
-0.74 
Finscreener Ranking
★★★★★     61.46
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★★★★     65.11
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★★★     71.59
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)2 029 
Earnings Rating
Price Range Ratio 52wk %
73.21 
Earnings Date

Today's Price Range

60.2561.13

52wk Range

42.5567.75

5 Year PE Ratio Range

5.3033.80

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
10.06%
3 Months
25.80%
6 Months
14.74%
1 Year
14.58%
3 Years
23.75%
5 Years
318.91%

Quotes

Name / TickerPriceChg.Chg.%
CBM61.000.30000.49
AAPL208.57-1.1800-0.56
GOOG1 213.54-28.5600-2.30
MSFT107.31-2.2500-2.05
XOM76.96-1.3500-1.72
WFC57.99-0.0800-0.14
JNJ129.660.16000.12
FB176.31-4.8000-2.65
GE12.17-0.1800-1.46
JPM113.55-1.1000-0.96
...

TickerPriceChg.%52 Week High
CMG520.485.51521.40
KMB115.624.04124.15
BSX34.622.7337.30
PCG43.772.1771.57
CLX144.742.04150.40
PGR63.501.9464.77
EIX68.251.9083.38
HCP26.781.9030.59
ED79.931.8089.70
LUV60.141.7866.99
ARE126.681.75134.37
HSY100.331.74115.82
HRL37.791.4838.00
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.00
Current Ratio 5.20
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage 374.70
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin41.00
EBIT Margin26.40
EBITDA Margin31.80
Pre-tax Profit Margin19.90
Profit Margin21.26
ValuationValueIndustryS&P 500US Markets
PE Ratio 16.90
PB Ratio 3.28
PS Ratios 3.56
Price to Cash Flow 15.90
Price to Free Cash Flow 29.10
Cash Flow Per Share 3.85
Price to Tangible Book3.60
Book Value per Share18.74
Enterprise Value (in ths.)1 870 710
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)21.19
ROE last 12 Months 22.31
Return on Assets (5Y Avg) 8.63
ROA last 12 Months 16.23
Return on Capital (5Y Avg) 18.37
ROC last 12 Months 22.31
Return on invested Capital Q 6.65
Return on invested Capital Y21.56
Assets Turnover0.30
Receivables Turnover2.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)574 082
Revenue per Share 17.26
Revenue Growth 3 Years 9.92
Revenue Growth 5 Years 13.68
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 20180.661.2183.33
Q01 20180.500.7244.00
Q04 20171.101.2715.45
Q03 20170.470.5517.02
Q02 20170.750.761.33
Q01 20170.510.6833.33
Q04 2016-1.18-
Q03 2016-0.44-
Earnings Per EndEstimateRevision %Trend
6/2018 QR0.66-9.59Negative
9/2018 QR0.6328.57Positive
12/2018 FY2.73-2.85Negative
12/2019 FY2.85-3.72Negative
Next Report Date2nd Aug 2018
Estimated EPS Next Report0.66
Estimates Count1
EPS Growth Next 5 Years %15.00
Volume Overview
Volume90 883
Shares Outstanding (in ths.)33 260
Trades Count673
Dollar Volume5 057 120
Avg. Volume344 372
Avg. Weekly Volume238 329
Avg. Monthly Volume425 377
Avg. Quarterly Volume388 521

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

65%35%

Bearish Bullish

47%53%

Bearish Bullish

53%47%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.40

There are no comments yet.

News

x